Browse
FDA applications
Approved and filed applications connected to their products and owning companies.
29,787 results
| Application | Applicant | Application number |
|---|---|---|
| BLA 761137 | Astellas Pharma US, Inc. | BLA761137 |
| BLA 761139 | Daiichi Sankyo, Inc | BLA761139 |
| BLA 761140 | Amgen Inc. | BLA761140 |
| BLA 761142 | Horizon Therapeutics Ireland DAC | BLA761142 |
| BLA 761143 | Horizon Therapeutics Ireland DAC | BLA761143 |
| BLA 761145 | Janssen Biotech, Inc. | BLA761145 |
| BLA 761146 | Endo Global Aesthetics Limited | BLA761146 |
| BLA 761147 | Accord BioPharma Inc. | BLA761147 |
| BLA 761148 | Assertio Specialty Pharmaceuticals, LLC | BLA761148 |
| BLA 761149 | Genentech, Inc. | BLA761149 |
| BLA 761150 | TERSERA THERAPEUTICS LLC | BLA761150 |
| BLA 761151 | UCB, Inc. | BLA761151 |
| BLA 761152 | Omeros Corporation | BLA761152 |
| BLA 761154 | Biocon Biologics Inc. | BLA761154 |
| BLA 761156 | Novo Nordisk Inc. | BLA761156 |
| BLA 761158 | GlaxoSmithKline Intellectual Property Development Ltd. England | BLA761158 |
| BLA 761161 | Chiesi Farmaceutici S.p.A. | BLA761161 |
| BLA 761163 | Incyte Corporation | BLA761163 |
| BLA 761164 | Recordati Rare Diseases, Inc. | BLA761164 |
| BLA 761165 | Sandoz Inc. | BLA761165 |
| BLA 761166 | PharmaEssentia Corporation | BLA761166 |
| BLA 761169 | Regeneron Pharmaceuticals, Inc. | BLA761169 |
| BLA 761170 | Genentech, Inc. | BLA761170 |
| BLA 761171 | Y-mABs Therapeutics, Inc | BLA761171 |
| BLA 761172 | Emergent BioDefense Operations Lansing LLC | BLA761172 |
| BLA 761173 | Fresenius Kabi USA, LLC | BLA761173 |
| BLA 761174 | GlaxoSmithKline LLC | BLA761174 |
| BLA 761175 | Biocon Biologics Inc. | BLA761175 |
| BLA 761177 | Ascendis Pharma Endocrinology Division A/S | BLA761177 |
| BLA 761178 | Biogen Inc. | BLA761178 |
| BLA 761179 | Jazz Pharmaceuticals Ireland Limited | BLA761179 |
| BLA 761180 | LEO Pharma A/S | BLA761180 |
| BLA 761181 | Regeneron Pharmaceuticals, Inc. | BLA761181 |
| BLA 761183 | Provention Bio, Inc. | BLA761183 |
| BLA 761184 | Pfizer Ireland Pharmaceuticals Unlimited Company | BLA761184 |
| BLA 761188 | Biocon Biologics Inc. | BLA761188 |
| BLA 761192 | Vericel Corporation | BLA761192 |
| BLA 761194 | Genzyme Corporation | BLA761194 |
| BLA 761195 | Argenx BV | BLA761195 |
| BLA 761196 | ADC Therapeutics SA | BLA761196 |
| BLA 761197 | Genentech, Inc. | BLA761197 |
| BLA 761198 | Bio-Thera Solutions, Ltd. | BLA761198 |
| BLA 761201 | Biocon Biologics Inc. | BLA761201 |
| BLA 761202 | Samsung Bioepis Co., Ltd. | BLA761202 |
| BLA 761204 | Amicus Therapeutics US, LLC | BLA761204 |
| BLA 761208 | Seagen Inc. | BLA761208 |
| BLA 761210 | Janssen Biotech, Inc. | BLA761210 |
| BLA 761211 | Immedica Pharma AB | BLA761211 |
| BLA 761212 | Lupin Limited (Biotech Division) | BLA761212 |
| BLA 761215 | Eli Lilly and Company | BLA761215 |